Brokerages predict that Genesco Inc. (NYSE:GCO) will announce $706.97 million in sales for the current fiscal quarter, according to Zacks. Three analysts have made estimates for Genesco’s earnings. The highest sales estimate is $712.00 million and the lowest is $703.20 million. Genesco reported sales of $710.82 million during the same quarter last year, which indicates a negative year-over-year growth rate of 0.5%. The firm is scheduled to report its next earnings report on Friday, December 1st.

On average, analysts expect that Genesco will report full year sales of $706.97 million for the current fiscal year, with estimates ranging from $2.83 billion to $2.89 billion. For the next year, analysts anticipate that the business will post sales of $2.89 billion per share, with estimates ranging from $2.80 billion to $2.93 billion. Zacks’ sales calculations are an average based on a survey of sell-side analysts that that provide coverage for Genesco.

Genesco (NYSE:GCO) last posted its quarterly earnings data on Thursday, August 31st. The company reported ($0.10) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.04). The firm had revenue of $616.50 million for the quarter, compared to analysts’ expectations of $626.93 million. Genesco had a net margin of 2.43% and a return on equity of 7.36%. The firm’s revenue was down 1.5% compared to the same quarter last year. During the same quarter last year, the company posted $0.34 EPS.

A number of analysts have commented on GCO shares. B. Riley reissued a “buy” rating and issued a $50.00 price objective on shares of Genesco in a report on Saturday, May 27th. Piper Jaffray Companies set a $39.00 price objective on Genesco and gave the company a “buy” rating in a report on Saturday, June 24th. Zacks Investment Research cut Genesco from a “hold” rating to a “strong sell” rating in a report on Thursday, June 1st. BidaskClub raised Genesco from a “strong sell” rating to a “sell” rating in a report on Monday, July 31st. Finally, Jefferies Group LLC reissued a “hold” rating and issued a $48.00 price objective on shares of Genesco in a report on Friday, July 14th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the stock. Genesco currently has a consensus rating of “Hold” and a consensus target price of $37.57.

TRADEMARK VIOLATION WARNING: “Zacks: Brokerages Anticipate Genesco Inc. (GCO) Will Post Quarterly Sales of $706.97 Million” was originally published by American Banking News and is owned by of American Banking News. If you are accessing this article on another domain, it was stolen and republished in violation of US & international copyright law. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/09/16/zacks-brokerages-anticipate-genesco-inc-gco-will-post-quarterly-sales-of-706-97-million.html.

Shares of Genesco (GCO) opened at 26.25 on Friday. The stock has a market cap of $522.87 million, a PE ratio of 7.37 and a beta of 1.29. The firm has a 50-day moving average price of $26.94 and a 200-day moving average price of $40.80. Genesco has a 12 month low of $20.90 and a 12 month high of $72.00.

In other news, SVP Mimi Eckel Vaughn acquired 10,000 shares of the business’s stock in a transaction on Wednesday, September 6th. The stock was bought at an average cost of $24.16 per share, for a total transaction of $241,600.00. Following the purchase, the senior vice president now owns 87,140 shares in the company, valued at $2,105,302.40. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Kevin Patrick Mcdermott acquired 1,000 shares of the business’s stock in a transaction on Thursday, July 6th. The shares were purchased at an average price of $32.32 per share, with a total value of $32,320.00. Following the completion of the purchase, the director now owns 8,657 shares in the company, valued at approximately $279,794.24. The disclosure for this purchase can be found here. In the last 90 days, insiders purchased 36,000 shares of company stock valued at $869,170. 3.30% of the stock is owned by company insiders.

A number of large investors have recently bought and sold shares of GCO. Quantbot Technologies LP acquired a new position in shares of Genesco during the 1st quarter worth approximately $105,000. Envestnet Asset Management Inc. boosted its holdings in shares of Genesco by 26.2% during the 1st quarter. Envestnet Asset Management Inc. now owns 2,347 shares of the company’s stock worth $130,000 after purchasing an additional 487 shares during the last quarter. State of Alaska Department of Revenue boosted its holdings in shares of Genesco by 77.8% during the 2nd quarter. State of Alaska Department of Revenue now owns 3,893 shares of the company’s stock worth $131,000 after purchasing an additional 1,703 shares during the last quarter. PNC Financial Services Group Inc. boosted its holdings in shares of Genesco by 44.0% during the 1st quarter. PNC Financial Services Group Inc. now owns 2,538 shares of the company’s stock worth $142,000 after purchasing an additional 775 shares during the last quarter. Finally, Tower Research Capital LLC TRC acquired a new position in shares of Genesco during the 2nd quarter worth approximately $144,000. Institutional investors own 95.93% of the company’s stock.

Genesco Company Profile

Genesco Inc is a retailer and wholesaler of footwear, apparel and accessories. The Company operates in five segments: Journeys Group, Schuh Group, Lids Sports Group, Johnston & Murphy Group and Licensed Brands. It relies on independent third-party manufacturers for production of its footwear products sold at wholesale.

Get a free copy of the Zacks research report on Genesco (GCO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Genesco (NYSE:GCO)

Receive News & Ratings for Genesco Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesco Inc. and related companies with MarketBeat.com's FREE daily email newsletter.